MED
Medifast, Inc.
Price Chart
Latest Quote
$12.12
+0.00 (+0.00%)
Current Price
| Previous Close | $12.12 |
| Open | $12.03 |
| Day High | $12.12 |
| Day Low | $12.12 |
| Volume | 1,293 |
Stock Information
| Shares Outstanding | 11.18M |
| Total Debt | $27.62M |
| Cash Equivalents | $169.82M |
| Revenue | $316.93M |
| Net Income | $-25.60M |
| Sector | Consumer Cyclical |
| Industry | Personal Services |
| Market Cap | $135.51M |
| EPS (TTM) | $-2.33 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-16.28M |
| Sales | $316.93M |
| Income | $-25.60M |
| Book/sh | $18.99 |
| Cash/sh | $15.19 |
| Employees | 380 |
Financial Ratios
| Quick Ratio | 4.09 |
| Current Ratio | 4.86 |
| Debt/Eq | 14.06 |
Returns & Margins
| ROA | -4.60% |
| ROE | -12.42% |
| Gross Margin | 69.24% |
| Operating Margin | -5.66% |
| Profit Margin | -8.08% |
Ownership
| Insider Ownership | 4.17% |
| Institutional Ownership | 76.42% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -43.29 |
| PEG | 0.97 |
| P/S | 0.43 |
| P/B | 0.64 |
Analyst Data
| Recommendation | none |
| Target Price | $12.00 |
Technical Indicators
| SMA20 | $11.95 |
| SMA50 | $11.01 |
| SMA200 | $11.16 |
| RSI | 66.91 |
| ATR | 0.3321 |
| Shares Float | 8.48M |
| Short Float | 16.90% |
| Short Ratio | 9.21 |
| Volatility | 0.70 |
| Rel Volume | 0.01 |
Performance History
| Week | +1.00% |
| Month | +23.30% |
| Quarter | -4.57% |
| 6 Months | +16.09% |
| YTD | +16.54% |
| Year | -13.55% |
| 3 Years | -85.33% |
| 5 Years | -94.00% |
| 10 Years | -57.35% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-09-01 | $12.12 | 1,293 |
| 2026-08-31 | $12.14 | 132,900 |
| 2026-08-27 | $12.16 | 70,700 |
| 2026-08-26 | $12.22 | 167,100 |
| 2026-08-25 | $12.16 | 97,700 |
| 2026-08-24 | $12.00 | 123,700 |
| 2026-08-21 | $11.95 | 178,500 |
| 2026-08-20 | $11.62 | 126,900 |
| 2026-08-19 | $11.58 | 129,400 |
| 2026-08-18 | $11.29 | 73,500 |
| 2026-08-17 | $11.44 | 161,100 |
| 2026-08-14 | $11.44 | 74,400 |
| 2026-08-13 | $11.48 | 89,800 |
| 2026-08-12 | $11.59 | 117,500 |
| 2026-08-11 | $11.65 | 77,900 |
| 2026-08-10 | $12.09 | 112,100 |
| 2026-08-07 | $12.62 | 140,500 |
| 2026-08-06 | $12.12 | 338,800 |
| 2026-08-05 | $12.28 | 347,600 |
| 2026-08-04 | $13.08 | 908,200 |
| 2026-08-03 | $9.74 | 250,800 |
About Medifast, Inc.
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.
đ° Latest News
3 Cash-Producing Stocks That Concern Us
StockStory âĸ 2026-08-31T13:58:24Z
Can Medifast Capitalize on Rising GLP-1 Use With Metabolic Health?
Zacks âĸ 2026-08-26T17:10:00Z
All You Need to Know About Medifast (MED) Rating Upgrade to Buy
Zacks âĸ 2026-08-26T16:00:04Z
AB InBev Leverages Premiumization and Digital Platforms for Growth
Zacks âĸ 2026-08-25T13:47:00Z
3 Unprofitable Stocks with Questionable Fundamentals
StockStory âĸ 2026-08-24T06:25:36Z
3 Reasons to Sell MED and 1 Stock to Buy Instead
StockStory âĸ 2026-08-21T18:27:47Z
Can Medifast's New Compensation Plan Accelerate Coach Growth?
Zacks âĸ 2026-08-21T15:25:00Z
3 Small-Cap Stocks with Questionable Fundamentals
StockStory âĸ 2026-08-20T10:19:15Z
Kenvue Q2 Deep Dive: Assessing Financial Metrics & Growth Prospects
Zacks âĸ 2026-08-12T17:31:00Z
Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?
Zacks âĸ 2026-08-12T16:35:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $110,601,000 | $157,840,000 | $296,204,000 | $458,163,000 |
| Cost Of Revenue | $110,601,000 | $157,840,000 | $296,204,000 | $458,163,000 |
| Total Revenue | $385,788,000 | $602,463,000 | $1,072,054,000 | $1,598,577,000 |
| Operating Revenue | $385,788,000 | $602,463,000 | $1,072,054,000 | $1,598,577,000 |
| Expenses | ||||
| Total Expenses | $400,001,000 | $599,585,000 | $945,652,000 | $1,413,771,000 |
| Other Income Expense | $3,058,000 | $-3,895,000 | $-95,000 | $-46,000 |
| Other Non Operating Income Expenses | $3,058,000 | $-3,895,000 | $-95,000 | $-46,000 |
| Net Non Operating Interest Income Expense | $5,516,000 | $4,804,000 | $2,490,000 | $-701,000 |
| Operating Expense | $289,400,000 | $441,745,000 | $649,448,000 | $955,608,000 |
| Interest Expense | - | - | - | $701,000 |
| Total Other Finance Cost | - | - | - | $701,000 |
| Interest Expense Non Operating | - | - | - | $701,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-18,672,000 | $2,091,000 | $99,415,000 | $143,568,000 |
| Net Interest Income | $5,516,000 | $4,804,000 | $2,490,000 | $-701,000 |
| Interest Income | $5,516,000 | $4,804,000 | $2,490,000 | - |
| Normalized Income | $-18,672,000 | $2,091,000 | $99,415,000 | $143,568,000 |
| Net Income From Continuing And Discontinued Operation | $-18,672,000 | $2,091,000 | $99,415,000 | $143,568,000 |
| Total Operating Income As Reported | $-14,213,000 | $2,878,000 | $126,402,000 | $184,806,000 |
| Net Income Common Stockholders | $-18,672,000 | $2,091,000 | $99,415,000 | $143,568,000 |
| Net Income | $-18,672,000 | $2,091,000 | $99,415,000 | $143,568,000 |
| Net Income Including Noncontrolling Interests | $-18,672,000 | $2,091,000 | $99,415,000 | $143,568,000 |
| Net Income Continuous Operations | $-18,672,000 | $2,091,000 | $99,415,000 | $143,568,000 |
| Pretax Income | $-5,639,000 | $3,787,000 | $128,797,000 | $184,059,000 |
| Interest Income Non Operating | $5,516,000 | $4,804,000 | $2,490,000 | - |
| Operating Income | $-14,213,000 | $2,878,000 | $126,402,000 | $184,806,000 |
| Gross Profit | $275,187,000 | $444,623,000 | $775,850,000 | $1,140,414,000 |
| Per Share | ||||
| Diluted EPS | $-1.70 | $0.19 | $9.10 | $12.73 |
| Basic EPS | $-1.70 | $0.19 | $9.10 | $12.82 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $29,000 | $15,585,000 | $139,509,000 | $195,740,000 |
| Reconciled Depreciation | $14,242,000 | $12,707,000 | $13,107,000 | $10,980,000 |
| EBITDA (Bullshit earnings) | $29,000 | $15,585,000 | $139,509,000 | $195,740,000 |
| EBIT | $-14,213,000 | $2,878,000 | $126,402,000 | $184,760,000 |
| Diluted Average Shares | $10,981,000 | $10,963,000 | $10,921,000 | $11,276,000 |
| Basic Average Shares | $10,981,000 | $10,930,000 | $10,884,000 | $11,195,000 |
| Diluted NI Availto Com Stockholders | $-18,672,000 | $2,091,000 | $99,415,000 | $143,568,000 |
| Tax Provision | $13,033,000 | $1,696,000 | $29,382,000 | $40,491,000 |
| Selling General And Administration | $289,400,000 | $441,745,000 | $649,448,000 | $955,608,000 |
Fetched: 2026-08-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $198,920,000 | $210,109,000 | $201,481,000 | $155,044,000 |
| Total Assets | $247,973,000 | $284,213,000 | $309,908,000 | $316,213,000 |
| Total Non Current Assets | $46,290,000 | $69,809,000 | $85,879,000 | $93,429,000 |
| Other Non Current Assets | $7,828,000 | $9,667,000 | $14,650,000 | $12,456,000 |
| Non Current Deferred Assets | $0 | $11,460,000 | $4,117,000 | $5,328,000 |
| Non Current Deferred Taxes Assets | $0 | $11,460,000 | $4,117,000 | $5,328,000 |
| Current Assets | $201,683,000 | $214,404,000 | $224,029,000 | $222,784,000 |
| Prepaid Assets | $14,182,000 | $9,639,000 | $19,397,000 | $0 |
| Inventory | $20,228,000 | $42,421,000 | $54,591,000 | $118,856,000 |
| Cash Cash Equivalents And Short Term Investments | $167,273,000 | $162,344,000 | $150,041,000 | $87,691,000 |
| Cash And Cash Equivalents | $89,303,000 | $90,928,000 | $94,440,000 | $87,691,000 |
| Cash Equivalents | $39,116,000 | $13,377,000 | $5,662,000 | - |
| Cash Financial | $50,187,000 | $77,551,000 | $88,778,000 | $87,691,000 |
| Other Current Assets | - | - | $10,670,000 | $16,237,000 |
| Debt | ||||
| Total Debt | $10,694,000 | $16,125,000 | $22,012,000 | $26,051,000 |
| Long Term Debt And Capital Lease Obligation | $6,091,000 | $9,943,000 | $16,127,000 | $20,275,000 |
| Current Debt And Capital Lease Obligation | $4,603,000 | $6,182,000 | $5,885,000 | $5,776,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $49,053,000 | $74,104,000 | $108,427,000 | $161,169,000 |
| Total Non Current Liabilities Net Minority Interest | $6,091,000 | $9,943,000 | $16,127,000 | $20,275,000 |
| Current Liabilities | $42,962,000 | $64,161,000 | $92,300,000 | $140,894,000 |
| Current Deferred Liabilities | $384,000 | $316,000 | $574,000 | $7,357,000 |
| Payables And Accrued Expenses | $37,975,000 | $57,663,000 | $85,841,000 | $127,761,000 |
| Payables | $29,272,000 | $43,633,000 | $63,734,000 | $103,940,000 |
| Other Payable | $6,727,000 | $8,914,000 | $13,277,000 | $23,633,000 |
| Dividends Payable | $295,000 | $648,000 | $1,407,000 | $19,641,000 |
| Total Tax Payable | $7,184,000 | $11,020,000 | $9,857,000 | $7,546,000 |
| Income Tax Payable | $0 | $1,485,000 | $0 | $428,000 |
| Accounts Payable | $15,066,000 | $23,051,000 | $39,193,000 | $53,120,000 |
| Equity | ||||
| Common Stock Equity | $198,920,000 | $210,109,000 | $201,481,000 | $155,044,000 |
| Total Equity Gross Minority Interest | $198,920,000 | $210,109,000 | $201,481,000 | $155,044,000 |
| Stockholders Equity | $198,920,000 | $210,109,000 | $201,481,000 | $155,044,000 |
| Gains Losses Not Affecting Retained Earnings | $234,000 | $180,000 | $248,000 | $24,000 |
| Other Equity Adjustments | $234,000 | $180,000 | $248,000 | $24,000 |
| Retained Earnings | $158,269,000 | $176,782,000 | $174,649,000 | $139,852,000 |
| Other | ||||
| Ordinary Shares Number | $10,991,273 | $10,937,830 | $10,896,000 | $10,873,000 |
| Share Issued | $10,991,273 | $10,937,830 | $10,896,000 | $10,927,000 |
| Tangible Book Value | $198,920,000 | $210,109,000 | $201,481,000 | $155,044,000 |
| Invested Capital | $198,920,000 | $210,109,000 | $201,481,000 | $155,044,000 |
| Working Capital | $158,721,000 | $150,243,000 | $131,729,000 | $81,890,000 |
| Capital Lease Obligations | $10,694,000 | $16,125,000 | $22,012,000 | $26,051,000 |
| Total Capitalization | $198,920,000 | $210,109,000 | $201,481,000 | $155,044,000 |
| Additional Paid In Capital | $40,406,000 | $33,136,000 | $26,573,000 | $21,555,000 |
| Capital Stock | $11,000 | $11,000 | $11,000 | $11,000 |
| Common Stock | $11,000 | $11,000 | $11,000 | $11,000 |
| Long Term Capital Lease Obligation | $6,091,000 | $9,943,000 | $16,127,000 | $20,275,000 |
| Current Deferred Revenue | $384,000 | $316,000 | $574,000 | $7,357,000 |
| Current Capital Lease Obligation | $4,603,000 | $6,182,000 | $5,885,000 | $5,776,000 |
| Current Accrued Expenses | $8,703,000 | $14,030,000 | $22,107,000 | $23,821,000 |
| Net PPE | $38,462,000 | $48,682,000 | $67,112,000 | $75,645,000 |
| Accumulated Depreciation | $-68,219,000 | $-58,341,000 | $-47,306,000 | $-39,941,000 |
| Gross PPE | $106,681,000 | $107,023,000 | $114,418,000 | $115,586,000 |
| Other Properties | $7,232,000 | $11,155,000 | $15,645,000 | $18,460,000 |
| Machinery Furniture Equipment | $77,369,000 | $74,175,000 | $73,709,000 | $70,656,000 |
| Buildings And Improvements | $21,735,000 | $21,348,000 | $24,499,000 | $25,905,000 |
| Land And Improvements | $345,000 | $345,000 | $565,000 | $565,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-4,342,000 | $-1,445,000 | $-2,266,000 | $-3,838,000 |
| Other Inventories | $1,654,000 | $1,429,000 | $1,962,000 | $3,611,000 |
| Finished Goods | $18,001,000 | $35,733,000 | $46,951,000 | $106,413,000 |
| Raw Materials | $4,915,000 | $6,704,000 | $7,944,000 | $12,670,000 |
| Other Short Term Investments | $77,970,000 | $71,416,000 | $55,601,000 | $0 |
| Treasury Shares Number | - | - | $0 | $54,000 |
| Treasury Stock | - | - | $0 | $6,398,000 |
Fetched: 2026-08-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,249,000 | $17,022,000 | $141,174,000 | $177,889,000 |
| Operating Activities | ||||
| Operating Cash Flow | $6,863,000 | $24,476,000 | $147,657,000 | $194,570,000 |
| Cash Flow From Continuing Operating Activities | $6,863,000 | $24,476,000 | $147,657,000 | $194,570,000 |
| Operating Gains Losses | $-1,937,000 | $-6,000 | $1,172,000 | $2,130,000 |
| Investing Activities | ||||
| Capital Expenditure | $-5,614,000 | $-7,454,000 | $-6,483,000 | $-16,681,000 |
| Investing Cash Flow | $-7,928,000 | $-26,520,000 | $-61,047,000 | $-11,414,000 |
| Cash Flow From Continuing Investing Activities | $-7,928,000 | $-26,520,000 | $-61,047,000 | $-11,414,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-369,000 | $-836,000 | $-6,960,000 | $-127,961,000 |
| Financing Cash Flow | $-564,000 | $-1,515,000 | $-79,789,000 | $-199,581,000 |
| Cash Flow From Continuing Financing Activities | $-564,000 | $-1,515,000 | $-79,789,000 | $-199,581,000 |
| Cash Dividends Paid | $-195,000 | $-715,000 | $-73,017,000 | $-71,620,000 |
| Common Stock Dividend Paid | $-195,000 | $-715,000 | $-73,017,000 | $-71,620,000 |
| Net Common Stock Issuance | $-369,000 | $-836,000 | $-6,960,000 | $-127,961,000 |
| Other | ||||
| Income Tax Paid Supplemental Data | $10,465,000 | - | $34,255,000 | $37,212,000 |
| End Cash Position | $89,303,000 | $90,928,000 | $94,440,000 | $87,691,000 |
| Beginning Cash Position | $90,928,000 | $94,440,000 | $87,691,000 | $104,183,000 |
| Effect Of Exchange Rate Changes | $4,000 | $47,000 | $-72,000 | $-67,000 |
| Changes In Cash | $-1,629,000 | $-3,559,000 | $6,821,000 | $-16,425,000 |
| Proceeds From Stock Option Exercised | $0 | $36,000 | $188,000 | $0 |
| Common Stock Payments | $-369,000 | $-836,000 | $-6,960,000 | $-127,961,000 |
| Net Investment Purchase And Sale | $-2,314,000 | $-19,066,000 | $-54,564,000 | $5,267,000 |
| Sale Of Investment | $82,093,000 | $27,529,000 | $5,192,000 | $5,267,000 |
| Purchase Of Investment | $-84,407,000 | $-46,595,000 | $-59,756,000 | $0 |
| Net PPE Purchase And Sale | $-5,614,000 | $-7,454,000 | $-6,483,000 | $-16,681,000 |
| Purchase Of PPE | $-5,614,000 | $-7,454,000 | $-6,483,000 | $-16,681,000 |
| Change In Working Capital | $-9,805,000 | $-9,745,000 | $20,276,000 | $21,651,000 |
| Change In Other Working Capital | $-6,601,000 | $10,212,000 | $-9,155,000 | $1,373,000 |
| Change In Other Current Assets | $-2,057,000 | $396,000 | $-4,694,000 | $-3,412,000 |
| Change In Payables And Accrued Expense | $-23,913,000 | $-34,994,000 | $-35,707,000 | $-37,594,000 |
| Change In Payable | $-23,913,000 | $-34,994,000 | $-35,707,000 | $-37,594,000 |
| Change In Account Payable | $-23,913,000 | $-34,994,000 | $-35,707,000 | $-37,594,000 |
| Change In Prepaid Assets | $573,000 | $2,471,000 | $5,567,000 | $97,000 |
| Change In Inventory | $22,193,000 | $12,170,000 | $64,265,000 | $61,187,000 |
| Other Non Cash Items | $4,624,000 | $16,179,000 | $4,607,000 | $6,098,000 |
| Stock Based Compensation | $7,639,000 | $7,363,000 | $8,188,000 | $11,053,000 |
| Unrealized Gain Loss On Investment Securities | $-17,000 | $4,089,000 | $-150,000 | $0 |
| Amortization Of Securities | $-671,000 | $-799,000 | $-169,000 | $14,000 |
| Deferred Tax | $11,460,000 | $-7,403,000 | $1,211,000 | $-924,000 |
| Deferred Income Tax | $11,460,000 | $-7,403,000 | $1,211,000 | $-924,000 |
| Depreciation Amortization Depletion | $14,242,000 | $12,707,000 | $13,107,000 | $10,980,000 |
| Depreciation And Amortization | $14,242,000 | $12,707,000 | $13,107,000 | $10,980,000 |
| Gain Loss On Investment Securities | $-3,310,000 | $-95,000 | - | - |
| Gain Loss On Sale Of PPE | $1,373,000 | $89,000 | $1,172,000 | $2,130,000 |
| Net Income From Continuing Operations | $-18,672,000 | $2,091,000 | $99,415,000 | $143,568,000 |
Fetched: 2026-08-15